StockData
Exelixis, Inc. logo

Exelixis, Inc. (EXEL) stock

EXELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends January 1
Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Oct 29, 2026Score 18/301% above fair value
$67.10−1.90 (-2.75%)

Close on Nov 16, 2026Market cap $16.37BP/E 20.1Yield –

Exelixis profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Exelixis's profit margin for the twelve months ending Oct 2, 2026 was 35.5%. For fiscal 2025 it was 33.7%, against 24.0% the year before. The highest annual figure on record is 80.8% in fiscal 2018.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Jan 2, 202633.7%+9.7
FY2024Jan 3, 202524.0%+12.7
FY2023Dec 29, 202311.4%+0.0
FY2022Dec 30, 202211.3%−4.8
FY2021Dec 31, 202116.1%+4.8
FY2020Jan 1, 202111.3%−21.9
FY2019Jan 3, 202033.2%−47.7
FY2018Dec 28, 201880.8%+46.7
FY2017Dec 29, 201734.1%+70.8
FY2016Dec 31, 2016-36.7%+398.4
FY2015Dec 31, 2015-435.1%+605.4
FY2014Dec 31, 2014-1040.6%−280.5
FY2013Dec 31, 2013-760.1%−453.8
FY2012Dec 31, 2012-306.3%−332.4
FY2011Dec 31, 201126.1%+76.0
FY2010Dec 31, 2010-49.9%+39.2
FY2009Dec 31, 2009-89.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Oct 2, 202633.1%+0.7
Q2 FY2026Jul 3, 202633.7%+1.2
Q1 FY2026Apr 3, 202634.5%+5.7
Q4 FY2025Jan 2, 202640.8%+16.2
Q3 FY2025Oct 3, 202532.4%+10.5
Q2 FY2025Jul 4, 202532.5%−3.0
Q1 FY2025Apr 4, 202528.7%+20.0
Q4 FY2024Jan 3, 202524.7%+6.8
Q3 FY2024Sep 27, 202421.9%+21.6
Q2 FY2024Jun 28, 202435.5%+18.2
Q1 FY2024Mar 29, 20248.8%−1.0
Q4 FY2023Dec 29, 202317.8%+24.9
Q3 FY2023Sep 29, 20230.2%−17.6
Q2 FY2023Jun 30, 202317.3%+0.4
Q1 FY2023Mar 31, 20239.8%−9.5
Q4 FY2022Dec 30, 2022-7.1%−28.2
Q3 FY2022Sep 30, 202217.8%+6.1
Q2 FY2022Jul 1, 202216.8%−8.1
Q1 FY2022Apr 1, 202219.3%+18.7
Q4 FY2021Dec 31, 202121.1%+10.6
Q3 FY2021Oct 1, 202111.6%+25.5
Q2 FY2021Jul 2, 202124.9%−0.8
Q1 FY2021Apr 2, 20210.6%−20.8
Q4 FY2020Jan 1, 202110.5%−18.1
Q3 FY2020Oct 2, 2020-13.9%−49.7
Q2 FY2020Jul 3, 202025.8%−7.1
Q1 FY2020Apr 3, 202021.4%−13.7
Q4 FY2019Jan 3, 202028.6%−128.9
Q3 FY2019Sep 27, 201935.9%−20.3
Q2 FY2019Jun 28, 201932.9%−14.1
Q1 FY2019Mar 29, 201935.2%−19.0
Q4 FY2018Dec 28, 2018157.5%+125.5
Q3 FY2018Sep 28, 201856.2%+2.8
Q2 FY2018Jun 29, 201847.0%+29.2
Q1 FY2018Mar 30, 201854.2%+33.6
Q4 FY2017Dec 29, 201732.1%−13.2
Q3 FY2017Sep 30, 201753.4%–
Q2 FY2017Jun 30, 201717.8%–
Q1 FY2017Mar 31, 201720.6%–
Q4 FY2016Dec 31, 201645.3%–

More Exelixis figures

See a number that looks wrong?